FDA Issues NAC Enforcement Discretion Guidance - Nutraceuticals World
The agency maintains NAC was first approved as a new drug before it was marketed as a dietary supplement, but may issue a rule following NPA request.| Nutraceuticals World
The agency maintains NAC was first approved as a new drug before it was marketed as a dietary supplement, but may issue a rule following NPA request.| Nutraceuticals World
In response letters, agency says NDI process not robust enough to ensure applicable safety standards are met.| Nutraceuticals World
Federal Register notice follows the recently released NDI guidance.| Nutraceuticals World
Increasingly, FDA has used this ‘race to market’ language of DSHEA to prevent or remove safe and legitimate dietary ingredients from commerce.| Nutraceuticals World
In response to multiple citizen petitions, the agency noted that NMN has been marketed in the U.S. since 2017.| Nutraceuticals World
